Form 4: Vaxcyte Executive Receives Stock Grant
Insider Transaction (Form 4)
Luis Jodar, Chief Medical Officer of Vaxcyte, Inc., reported multiple transactions in common stock on September 4, 2026.
Summary
- Grant/award: acquired 52,632 Common Stock on September 4, 2026; holds 52,632 after (Direct).
- Grant/award: acquired 88,254 Stock Option (right to buy) on September 4, 2026; holds 88,254 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Luis Jodar — Officer (Chief Medical Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-04 | Grant/award | Common Stock | 52,632 | — | — | 52,632 |
| 2026-09-04 | Grant/award | Stock Option (right to buy) | 88,254 | — | — | 88,254 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-04 | Grant/award (52,632 shares) |
| 2026-09-04 | Grant/award (88,254 shares) |
Keywords
insider transaction, Form 4, PCVX, Vaxcyte, Inc., neutral, Luis Jodar
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.